In past years, the abnormal expression or altered epigenetic modification of PD-associated genes including PARK1-15, LRRK2, SNCA, MAPT, and GBA were suggested to be associated with PD pathology [9, 10]. This evidence concerns the gene LRRK2 and Parkinson disease.